Filing Details
- Accession Number:
- 0000891293-14-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-07 19:10:40
- Reporting Period:
- 2014-05-05
- Filing Date:
- 2014-05-07
- Accepted Time:
- 2014-05-07 18:10:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891293 | Cell Therapeutics Inc | CTIC | Pharmaceutical Preparations (2834) | 911533912 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557551 | Matthew Plunkett | 3101 Western Avenue, Suite 600 Seattle WA 98121 | Evp, Corporate Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-05-05 | 300 | $2.93 | 620,604 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-05 | 1,100 | $2.93 | 619,504 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-05 | 300 | $2.94 | 619,204 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-05 | 1,100 | $2.94 | 618,104 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-05 | 745 | $2.95 | 617,359 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-05 | 400 | $2.96 | 616,959 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-05 | 1,300 | $2.96 | 615,659 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-05 | 2,400 | $2.97 | 613,259 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-05 | 100 | $2.97 | 613,159 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-05 | 3,517 | $2.97 | 609,642 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-05 | 700 | $2.98 | 608,942 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-05-05 | 38 | $2.98 | 608,904 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale was effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
